Please login to the form below

Not currently logged in
Email:
Password:

Astellas Pharma UK

This page shows the latest Astellas Pharma UK news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Orchard raises $150m, Astellas swoops for early-stage gene company, Amicus gets FDA Fabry approval

Daily Brief: Orchard raises $150m, Astellas swoops for early-stage gene company, Amicus gets FDA Fabry approval

Astellas acquires UK gene therapy company Quethera. Japan’s Astellas Pharma is to acquire UK-based gene therapy company Quethera for $85m. ... Yasukawa, Ph.D., who took over as president and CEO of Astellas in February.

Latest news

  • PMEA 2009: Winners announced

    Company: Astellas Pharma UK. In association with: Pan Advertising. Highly Commended:. Title of Entry: Remicade: Futures Remade. ... Winner:. Astellas Pharma. Highly Commended:. Daiichi Sankyo UK.  . Sponsored by:IDIS.

  • New cancer drug being tested

    Professor Paul Workman, head of Cancer Research UK Centre for Cancer Therapeutics at The Institute, said: "This is a significant milestone in the development of a new drug which has the ... GDC-0941 was discovered at Piramed Limited, a UK-based

  • Signs of change

    This sentiment is echoed by the words of Dudley Ferguson, managing director of Astellas Pharma UK, who believes that pharma's biggest challenge is to realign its priorities and stare change ... in the UK as it is the very best way to have excellent

More from news
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics